• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRIUM MEDICAL CORPORATION ADVANTA V12 COVERED; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRIUM MEDICAL CORPORATION ADVANTA V12 COVERED; STENT, ILIAC Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Renal Failure (2041); Sepsis (2067)
Event Type  Injury  
Manufacturer Narrative
On completion of the investigation, a follow up report will be submitted.
 
Event Description
Received an article: silverberg, d.E.(2020).Chimney endovascular repair of primary mycotic aneurysms involving the paravisceral aorta.Annals of vascular surgery, 59-66.Purpose: the purpose of this study is to report an experience with chimney evar (chevar) in patients with mycotic aortic aneurysms.Method: a retrospective review of all patients treated with evar at our institution between 2009 and 2019.Conclusion: chevar is a feasible and safe treatment modality for maas involving the visceral segment.Per the article adverse events included renal failure and sepsis.
 
Manufacturer Narrative
This complaint is based on information within an article and no specific device information has been provided.As there is insufficient details of an actual device malfunction or adverse event that occurred the complaint cannot be confirmed.A device history record (dhr) review was unable to be performed as the device product part number and lot number was not provided within the article.Conclusion: considering the design of the study, excellent technical success rate, no stent occlusion of the pgs occurred, no required reintervention due to endoleaks and the fact that no patient required explanation of the stent grafts or conversion to an open repair, one can infer that the getinge¿s advanta v12 balloon expandable covered bridging stents performed as expected.Authors emphasized that intentional occlusion of the selected visceral arteries was required to minimize the risk of gutter endoleaks in this urgent setting.H3 other text: product not available.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANTA V12 COVERED
Type of Device
STENT, ILIAC
Manufacturer (Section D)
ATRIUM MEDICAL CORPORATION
40 continental blvd
merrimack NH
Manufacturer (Section G)
ATRIUM MEDICAL CORPORATION
40 continental blvd
merrimack NH
Manufacturer Contact
lori gosselin
40 continental blvd
merrimack, NH 
MDR Report Key11389396
MDR Text Key233963938
Report Number3011175548-2021-00248
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
Reporter Country CodeIS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/26/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/10/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-